Cytosorbents

$8.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.09 (+1.01%) Today
$0.00 (0.00%) As of 9:14 PM UTC after-hours

Why Robinhood?

You can buy or sell Cytosorbents and other stocks, options, and ETFs commission-free!

About CTSO

CytoSorbents Corp. engages in the critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio include CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb.

CEO
Phillip P. Chan
Employees
195
Headquarters
Monmouth Junction, New Jersey
Founded
2002
Market Cap
383.70M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
198.61K
High Today
$9.01
Low Today
$8.80
Open Price
$9.00
Volume
114.01K
52 Week High
$11.74
52 Week Low
$7.13

CTSO Earnings

-$0.22
-$0.15
-$0.07
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 4, After Hours

You May Also Like

BOWX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure